Industries
Medical Devices
Product development portfolios, regulatory programs, and lifecycle management for medical device organizations operating in an increasingly complex regulatory environment.
The medical device challenge
Medical device organizations face a regulatory environment that has grown substantially more demanding — with MDR in Europe, evolving FDA pathways, and increasing scrutiny of post-market surveillance. At the same time, product portfolios are growing more complex, with software, combination products, and connected devices adding new dimensions of risk and compliance.
Tarseva helps medical device organizations manage this complexity — from portfolio prioritization and regulatory strategy through product development program management and lifecycle extension.
Key challenges
Where medical device organizations get stuck
Regulatory complexity
Navigating evolving regulatory pathways across multiple geographies — FDA, MDR, and beyond — with programs at different stages of development and approval.
Portfolio breadth
Managing product portfolios that span hardware, software, combination products, and connected devices — each with distinct development, regulatory, and lifecycle requirements.
Post-market obligations
Meeting increasingly demanding post-market surveillance, clinical follow-up, and periodic safety update requirements across a broad product portfolio.
Innovation pipeline
Balancing investment in the existing portfolio with the development of next-generation products and platforms.
How we help
Capabilities we bring to medical devices
Ready to bring discipline to your device portfolio?
Talk to Tarseva about how we work with medical device organizations.